Factors of Drug-Receptor Interaction

In terms of drug-receptor interaction, several factors are crucial for understanding how drugs work in the body (AES):

Definition: Affinity refers to the inherent attraction between the drug and its target receptor.
Importance:
- It is a measure of how tightly a drug binds to its receptor.
- A higher affinity means stronger binding and a longer duration of action.
- Conversely, drugs with lower affinity will bind weaker, potentially leading to shorter effects and a greater chance of dissociation from the receptor.

Definition: Efficacy describes the ability of a drug, once bound to the receptor, to create a biological effect similar to that of endogenous ligands (the body's natural signaling molecules).
Types of Drug Actions:
- Agonists: These drugs have an intrinsic activity of 1, meaning they fully activate the receptor, producing a maximum response.
- Partial Agonists: They have intrinsic activity between 0 and 1, providing a sub-maximal response even when fully bound to the receptor.
- Antagonists: These drugs possess an intrinsic activity of 0, meaning they do not activate the receptor but block it from being activated by agonists.

Definition: Specificity refers to the ability of a drug to selectively bind to a particular receptor type, minimizing side effects.
Example: The adrenergic receptors include various types such as alpha-1, alpha-2, beta-1, and beta-2, each having distinct roles in different tissues.
- Beta-1 Receptors: Located in the heart, stimulation causes increased inotropic activity, elevated heart rate, and enhanced cardiac conduction velocity and automaticity.
- Beta-2 Receptors: Found in the lungs, their stimulation causes bronchodilation, which is crucial for easing breathing in conditions like bronchial asthma.

Selectivity in Treatment: In treating conditions like bronchial asthma, it is desirable to stimulate beta-2 receptors selectively to achieve bronchodilation without affecting other receptors that may lead to adverse effects.
- For instance, non-selective drugs may activate alpha-1 and beta-1 receptors, potentially causing vasoconstriction and increased heart rate, respectively—an issue for patients with concurrent cardiac conditions.
- Conversely, selective drugs reduce these unwanted side effects, increasing patient tolerance and acceptability.
Examples of Selective Drugs:
- Selective beta-2 agonists like terbutaline, salbutamol, fenoterol, formoterol, and bambuterol are designed specifically for asthma treatment with minimal side effects.
- Selective beta-1 antagonists, such as atenolol, nebivolal, bisoprolol, and metoprolol, target hypertension and tachycardia while sparing beta-2 receptors to prevent bronchoconstriction in asthmatic patients.